DAN BOLLAG, PHD
Chief Strategy Officer at Ocular Therapeutix
Daniel Bollag, Ph.D., brings over 25 years of R&D and executive regulatory leadership experience with biopharmaceutical companies. Having gained a plethora of experience over his career, Dan now serves as a Regulatory and Executive Biotech Consultant to his portfolio of clients. Prior to his consulting career, Dan served as the Chief Strategy Officer at Ocular Therapeutix, as well as Senior Vice President of Regulatory Affairs, Pharmacovigilance & Quality at Ariad Pharmaceuticals. During his tenure at Ariad, his responsibilities included the regulatory oversight of Iclusig® (ponatinib) and Alunbrig™ (brigatinib) from Phase 1 through accelerated regulatory approvals.
Dan earned undergraduate degrees at the Pennsylvania State University and a doctorate in Biochemistry at Cornell University.